Latest webinar

The Role of Biopharmaceutics in Early Drug Development

Downloading our Scientific Posters

You are about to download this document, please enter your contact details below to start downloading.

Scientific Posters

A Phase I, open-label, 2-Part study to establish absolute bioavailability - DMDG 2016

A Phase I, open-label, 2-Part study to establish absolute bioavailability and the ADME of evogliptin in healthy male subjects by light-label approach.

Would you like to receive further scientific content including case studies, whitepapers and seminar and webinar invitations?
You can find out how we handle your personal information in our privacy policy here.

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.